Prosecution Insights
Last updated: April 19, 2026

Examiner: JONES, CHRISTINE MICHELLE

Tech Center 1600 • Art Units: 1682

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
16
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

2.6%
§101 Eligibility
20.5%
§102 Novelty
29.5%
§103 Obviousness
25.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18534113 FLOW CELLS AND SEQUENCING KITS Non-Final OA ILLUMINA, INC.
18506858 METHODS AND COMPOSITIONS FOR COPY-NUMBER INFORMED TISSUE-OF-ORIGIN ANALYSIS Non-Final OA GUARDANT HEALTH, INC.
18478392 REDUCING SPATIAL OCCUPANCY OF MOLECULES IN A SAMPLE THROUGH SAMPLE CROSSLINKING Non-Final OA 10x Genomics, Inc.
18561259 Next-Generation Volumetric in Situ Sequencing Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18279769 METHODS AND DEVICES FOR NUCLEIC ACID DETECTION Non-Final OA The Regents of the University of Colorado, a Body Corporate
17580364 MICROFLUIDIC DEVICE FOR SARS-COV-2 DETECTION AND METHOD USING THE SAME Non-Final OA National Tsing Hua University
18458354 REACTION COMPOSITION FOR NUCLEIC ACID AMPLIFICATION AND NUCLEIC ACID AMPLIFICATION METHOD USING SAME Final Rejection NOF CORPORATION
18563211 IMPROVEMENTS IN OR RELATING TO DIGESTION OF REACTION PRODUCTS Non-Final OA LumiraDx UK Ltd.
18506147 Method for detection of single nucleotide variant Non-Final OA KAOHSIUNG MEDICAL UNIVERSITY
18551590 TARGET NUCLEIC ACID AMPLIFICATION METHOD USING GUIDE PROBE AND CLAMPING PROBE AND COMPOSITION FOR AMPLIFYING TARGET NUCLEIC ACID COMPRISING SAME Non-Final OA HLB PANAGENE CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month